Commercial influence and covid-19-Reference-Cited by-同舟云学术

Commercial influence and covid-19

Published:2020-06-24 Issue: Volume: Page:m2456
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Moynihan Ray,Macdonald Helen,Bero Lisa,Godlee Fiona

Publisher

BMJ

Subject

General Engineering

Reference16 articles.

1. Pathways to independence: towards producing and using trustworthy evidence

2. What happens when the world’s biggest medical device maker becomes a “health services provider”?

3. Covid-19: Confidentiality agreements allow antibody test manufacturers to withhold evaluation results

4. Talk Evidence covid-19 update—lack of testing transparency, how to give good debate. BMJ Talk Evidence podcast, May 2020. https://soundcloud.com/bmjpodcasts/talk-evidence-covid-19-update-lack-of-testing-transparency-how-to-give-good-debate

5. Global regulatory agility during covid-19 and other health emergencies

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Commercial Determinants of Health and Evidence Synthesis (CODES): methodological guidance for systematic reviews and other evidence syntheses;Systematic Reviews;2023-09-14

2. Treatment effect of remdesivir on the mortality of hospitalised COVID-19 patients in Switzerland across different patient groups: a tree-based model analysis;Swiss Medical Weekly;2023-08-28

3. Professional ethics for infectious disease control: moral conflict management in modern public health practice;Public Health;2023-08

4. Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic;Therapies;2022-11

5. A framework is proposed for defining, categorizing, and assessing conflicts of interest in health research;Journal of Clinical Epidemiology;2022-09